2010 Cancer Center Business Summit
The Impact of Health Reform on Oncology
October 7 & 8, 2010
The Palmer House Hilton
 

Program Agenda
(as of August 30, 2010, subject to change)
 

Wednesday, October 6, 2010
Time	Event
5:00 p.m.	Registration
Thursday, October 7, 2010
Time	Event
7:00 a.m. - 7:50 a.m.	Registration and Networking Continental Breakfast
8:00 a.m. - 8:15 a.m.	Welcome and Introduction Michael L. Blau, J.D., Chair, Health Care Venture Practice, Partner, Foley & Lardner LLP
8:15 a.m. - 9:40 a.m.	Original Research Results Summit Survey Results Ronald Barkley, M.S., J.D., Executive Director, US Oncology Teri U. Guidi, MBA, FAAMA, President & CEO, The Oncology Business Institute Results of the National Practice Benchmark, 2010 Report Elaine L. Towle, CMPE, Director, Consulting Services, Oncology Metrics, a division of Altos Solutions Oncology Roundtable Results Allison Cuff Shimooka, Practice Manager, Oncology Roundtable, The Advisory Board Company
9:40 a.m. - 10:00 a.m.	Networking Break
10:00 a.m. - 11:00 a.m.	Washington Update: Medical Oncology Perspective Barbara L. McAneny, M.D., Chief Executive Officer, New Mexico Oncology Hematology Consultants Washington Update: Radiation Oncology Perspective David C. Beyer, M.D., Chair, Health Policy Council ASTRO Arizona Oncology Services
11:00 a.m. - 11:20 a.m.	Networking Break
11:20 a.m. - 12:45 p.m.	Payor Panel Moderator: Bruce Cutter, M.D., MMM Panelists: Kathleen G. Lokay, President, Via Oncology John E. Hennessy, Executive Director, Kansas City Cancer Center Lesli Lord, Executive Director, Oncology Physician Resources, PLLC, Physician Resource Management, Inc. Marcus Neubauer, M.D., Kansas City Cancer Center Anne Rice Grannis, Director, Network Contracting; Oncology Line of Services, UnitedHealthcare Barry Russo, Chief Executive Officer, The Center for Cancer and Blood Disorders
12:45 p.m. - 2:00 p.m.	Networking Luncheon Presentation of the annual Foley & Lardner LLP Cancer Center Innovator Award Keynote: A Washington Insider’s View on Health Reform Mark McClellan, M.D., PH.D., Director, Engelberg Center for Health Care Reform and Leonard D. Schaeffer Chair, Health Policy Studies, The Brookings Institution and Former CMS Administrator
2:00 p.m. - 5:30 p.m.	SUCCESSFUL MODELS FOR AFFILIATING WITH HOSPITALS FOR COMPREHENSIVE CANCER CARE
2:00 p.m. - 3:00 p.m.	New Models of Provider Integration: ACOs and Payment Bundles John M. Bertko, F.S.A., M.A.A.A., Visiting Scholar, The Brookings Institution and adjunct staff at RAND. Brett M. Hickman, Partner, PricewaterhouseCoopers, LLP Matt Brow, Vice President, Corporate Communication, Government Relations and Public Policy, US Oncology
3:00 p.m. - 3:20 p.m.	Networking Break
3:20 p.m. - 4:20 p.m.	Hospital Affiliation Models that Preserve Private Practice Michael L. Blau, J.D., Chair, Health Care Venture Practice, Partner, Foley & Lardner LLP Kelley D. Simpson, Senior Partner, Oncology Solutions, LLC
4:20 p.m. - 5:30 p.m.	Case Studies and Reactor Panel: Case Study #1: Memorial Hospital at Gulfport and The Medical Oncology Group, P.A. Kent Nicaud, Vice President, Physician Administrative Services, Memorial Hospital at Gulfport Martin Shenk, Chief Operating Officer, The Medical Oncology Group, P.A. Case Study #2: Union Hospital, Terre Haute, IN Patrick Board, Chief Executive Officer, Associated Physicians & Surgeons Clinic Case Study Reactor Panel: Roy Beveridge, M.D., Executive Vice President & Medical Director, US Oncology Michael Borton, Practice Manager and Chief Operating Officer, Hematology Oncology Patient Enterprise (H.O.P.E.) John V. Cox, D.O., Texas Oncology, Past Chair, ASCO Clinical Practice Committee William Jordan, D.O., Founder, The Center for Cancer and Blood Disorders Paul O'Dea, Chief Operating Officer, Aptium Oncology
	Day One Summary and Wrap-Up
Immediately Following	Networking Reception
Friday, October 8, 2010
Time	Event
7:00 a.m. - 7:50 a.m.	Sunrise Session Oncology Legal Update C. Frederick Geilfuss II, J.D., Partner, Foley & Lardner LLP Robert D. Sevell, J.D., Co-Chair, Health Information Group, Partner, Foley & Lardner LLP Judith Waltz, J.D., Co-Chair, Life Sciences Industry Team, Partner, Foley & Lardner LLP
	Track A	Track B
8:00 a.m. - 8:50 a.m.	Practice Consolidations: SuperGroups and Multi-Specialty Integration Michael L. Blau, J.D., Chair, Health Care Venture Practice, Partner, Foley & Lardner LLP Bruce Cutter, M.D., MMM Leonard Kalman, M.D., Advanced Medical Specialists	Multi-Disciplinary Care Case Studies: Lessons Learned Mark Krasna, M.D., Medical Director, The Cancer Institute, St. Joseph Medical Center Barbara L. McAneny, M.D., Chief Executive Officer, New Mexico Oncology Hematology Consultants Ltd. Rhonda S. Mealor, Senior Managing Partner, Oncology Solutions, LLC
9:00 a.m. - 9:50 a.m.	Aligning Oncologist-Hospital Interests through Co-Management Arrangements Michael L. Blau, J.D., Chair, Health Care Venture Practice, Partner, Foley & Lardner LLP Daryl P. Johnson, MAcc, AVA, Principal, HealthCare Appraisers, Inc.	The Business Case for Quality and Efficiency: Will Payors By It? Thomas R. Barr, MBA, Chief Operating Officer, Oncology Metrics, a division of Altos Solutions John E. Hennessy, Executive Director, Kansas City Cancer Care
10:00 a.m. - 10:50 a.m.	Trends in Compensating Oncologists in Hospitals and Groups Ronald Barkley, M.S., J.D., Executive Director, US Oncology Teri U. Guidi, MBA, FAAMA, President and Chief Executive Officer, Oncology Management Consulting Group Jessica Turgon, Senior Manager, ECG Management Consultants, Inc.	Health Reform and Oncology EMR Investment: Leveraging Information Technology and Meaningful Use Moderator: John V. Cox, D.O., Past Chair, Member of ASCO’s EHR Workgroup; Editor-in-Chief, Journal of Oncology Practice Warren M. Dodge, President, Altos Solutions William M. Herman, Senior Vice President, Operational Excellence & Product Development, US Oncology Ken Hotz, Ph.D. Senior Product Manager Varian Oncology Palo Alto, California
11:00 a.m. - 11:50 a.m.	Oncology Benefit Management by Payers: Who and How, and What Practices Can Do Dawn Holcombe MBA, FACMPE, ACHE, DGH Consulting; Connecticut Oncology Association	Specialty Pharmacy "Brown Bagging" Mandates: Is It Coming to a Payor Near You? Burt Zweigenhaft, Chief Executive Officer, OncoMed The Oncology Pharmacy Michael J. Anderson, M.D., President, Commonwealth Hematology- Oncology
12:00 p.m.	Summit Adjourns